Award Winners from Cancer Metastasis Through the Lymphovascular System: Biology and Treatment, from the Trainee & Young Investigator Session on Saturday, April 22, 2017

Trainee & Young Investigator Session

2nd Place Trainee

Isaac Adjei, PhD, Department of Biomedical Engineering, University of Florida; Department of Biomedical Engineering, Gainesville, USA

3rd Place Trainee

Maris Jones, MD, et al, Division of Surgical Oncology, John Wayne Cancer Institute, Providence Saint John’s Health Center, Santa Monica, USA

1st Place Young Investigator

Diego Marzese, PhD, Department of Translational Molecular Medicine, John Wayne Cancer Institute at Providence Saint John’s Health Center, Santa Monica, ­USA

2nd Place Young Investigator

Corrado Campisi, MD, RAS-ACS, IRCCS, Department of Plastic, Reconstructive & Aesthetic Surgery, Unit for Lymphatic Microsurgery, Salus Hospital, GVM Care & Research, Reggio Emilia, Italy

3rd Place Young Investigator

Robert Holt, PhD, inviCRO, LLC, Boston, USA

To View Full Abstracts fro 2017 Awards Session, please click here

1st Place Trainee: Intravital imaging of lymph node metastasis reveals its ability to contribute to distant metastasis,
Ethel Pereira, Dmitriy Kedrin, Giorgio Seano, Olivia Gautier, Dennis Jones, Eelco Meijer, Shan-Min Chin, Shuji Kitahara, Jonathan Chang, Elizabeth Beech, Han-Sin Jeong, Michael Carroll, Alphonse Taghian, Timothy Padera
2nd Place Trainee: Nanoparticle to treat established lymph node metastasis and primary tumor, Isaac Adjei, Vinod Labhasetwar
3rd Place Trainee: Cutaneous Immune Factors and Regression of In-Transit/Lymphatic Melanoma After Intralesional Injection of Bacille Calmette-Guerin, Maris Jones, Junbao Yang, Leland Foshag, Peter Sieling, Delphine Lee, Mark Faries
1st Place Young Investigator: Epigenetic alterations of spliceosome factors are associated with organ-specific melanoma metastasis, Diego Marzese, Nellie Nelson, Ling Takeshima, Sandy Hsu, Dave Hoon
2nd Place Young Investigator: Innovations in Lymphatic Microsurgery –  MLVA and FLA-LVSP: The Complete Treatment Package, Corrado Campisi
3rd Place Young Investigator: Cryofluorescence Tomography for Single-Cell and Micron-Level of Analysis of Cancer Metastasis and the Lymphovascular System – Bridging the Microscopic/Mesoscopic Divide, Robert Holt, Mark Bordo, Sanjana Pannem, Jacob Hesterman, John Frangioni, Jack Hoppin, Ajay Verma

Trainee &Young Investigator Awards

On behalf of the Organizing Committee, we are pleased to sponsor a Trainee and Young Investigator Abstract Awards contest to motivate, encourage and mentor the next generation of cancer researchers. Selection of the award recipients will be based upon the abstract grade and ranking and will be as follows:

  • 1st Place Trainee Abstract Award and 1st Place Young Investigator Abstract Award: $1,000 each
  • 2nd Place Trainee Abstract Award and 2nd Place Young Investigator Abstract Award: $750 each
  • 3rd Place Trainee Abstract Award and 3rd Place Young Investigator Abstract Award: $500 each

In addition to the Award stipend, recipients will be given the recognition of presenting their talk during the Trainee & Young Investigator Abstract Award Session and will receive a complimentary registration and an Award Plaque. Award winners will also be invited to submit a manuscript for a special meeting Issue of Clinical and Experimental Metastasis, which will be dedicated to selected presentations from the Congress.

Those wishing to apply for the Trainee or Young Investigator Awards MUST meet the following eligibility requirements:

  • Apply before June 1, 2019 abstract submission deadline through the “Awards” step of the online abstract submission site.
  • Be an undergraduate, graduate, or postgraduate student, postdoc, resident, fellow, or qualifying trainee (for Trainee Awards).
  • Be within 5 years of completion of training (for Young Investigator Awards).
  • Trainees should upload a letter confirming their training status and Young Investigators should upload a CV confirming they are within 5 years of completion of training through the online abstract system. Please click the green menu button “Trainee Status or Young Investigator CV” to upload the appropriate document at the time of abstract submission.
  • Be the first author and presenter of the accepted abstract.

Instructions for the submission of an abstract

  1. The conference language is English and all abstracts must be submitted in English.
  2. Abstracts must be submitted online. Do not fax, mail or email your abstract as it will not be considered.
  3. In order to give an Poster and/or Oral presentation at the conference, please submit an abstract by the June 1, 2019 deadline. The Poster can be prepared after you have received a message, accepting your contribution, from the Organizing Committee.
  4. Please note that papers can only be accepted if at least one author is registered for the conference. The online registration system and the online abstract system are connected, but a meeting registration must be completed in addition to the abstract submission, at least 45 days prior to the start of the meeting.
  5. Abstracts should be no more than 500 words excluding title, authors, and affiliations.
  6. Abstracts should be formatted with the following headings: Background, Materials and Methods, Results, and Conclusions.

Abstracts will be reviewed by the Organizing Committee from June 1 – June 30, 2019 Acceptance notices will be sent via email by mid-July, 2019.

Abstracts will be tentatively divided into 2 major categories and their subcategories:

  • Tumor Microenvironment and Cancer Progression
    • Cancer Initiation
    • Cancer Growth
    • Cancer Progression

  • Cancer Metastasis & Treatment

    • Cancer Cell Trafficking
    • Sentinel Lymph Node Metastasis
    • Systemic Metastasis
    • Biomarkers of Cancer Metastasis
    • Treatment of Cancer Metastasis
    • Treatment of Secondary Lymphedema from Cancer Therapy

Presentation Type: Abstract authors can request the following types of presentation:

  • Poster Presentation Only
  • Oral Presentation
  • Poster OR Oral Presentation (allow the Organizing Committee to decide)